CD86 and melanoma: The monocytes associated with melanoma are restrained in their expression of CD80 and CD86 co-stimulatory molecules but retain CD14 and HLA class II expression, thus finally promoting the expansion of CD11b+/Gr-1+ MDSCs [82].